Stem cell-like brain tumor initiating cells (BTICs) cause recurrence of glioblastomas, with BTIC 'stemness' affected by epigenetic mechanisms. The ING family of epigenetic regulators (ING1-5) function by targeting histone acetyltransferase (HAT) or histone deacetylase complexes to the H3K4me3 mark to alter histone acetylation and subsequently, gene expression. Here we find that ectopic expression of ING5, the targeting subunit of HBO1, MOZ and MORF HAT complexes increases expression of the Oct4, Olig2 and Nestin stem cell markers, promotes self-renewal, prevents lineage differentiation and increases stem cell pools in BTIC populations. This activity requires the plant homeodomain region of ING5 that interacts specifically with the H3K4me3 mark. ING5 also enhances PI3K/AKT and MEK/ERK activity to sustain self-renewal of BTICs over serial passage of stem cell-like spheres. ING5 exerts these effects by activating transcription of calcium channel and follicle stimulating hormone pathway genes. In silico analyses of The Cancer Genome Atlas data suggest that ING5 is a positive regulator of BTIC stemness, whose expression negatively correlates with patient prognosis, especially in the Proneural and Classical subtypes, and in tumors with low SOX2 expression. These data suggest that altering histone acetylation status and signaling pathways induced by ING5 may provide useful clinical strategies to target tumor resistance and recurrence in glioblastoma.
INTRODUCTION
Glioblastoma multiforme (GBM) is the most frequent and lethal type of intracranial tumor with a five-year survival rate of 5.1%. 1, 2 An intratumoral lineage hierarchy has been uncovered following the identification of tumor initiating cells in brain tumors, 3, 4 and the progenitor-like status of brain tumor initiating cells (BTICs) is thought to make gliomas particularly refractory to standard cancer treatments. Primary cultures of BTICs can establish tumors during serial in vivo transplantation 5, 6 and repopulate tumor sites after irradiation and chemotherapy. 7, 8 BTICs display a combination of neural stem cell phenotypes and tumorigenic properties, and may originate from crosstalk between deregulated developmental processes and mitogenic mutations during gliomagenesis. 9 Both neurodevelopmental factors and mitogenic signaling pathways contribute to the 'stemness character' of BTICs. For example, the Notch and inhibitor of differentiation (ID) proteins promote selfrenewal in both neural stem cells and BTICs. [10] [11] [12] EGFR and PDGFR activation, the most common genetic aberrations in gliomas, can induce de-differentiation of mature astrocytes to cause gliomagenesis in mouse models, 13, 14 and promote BTIC maintenance in vitro. 15 Epigenetic alterations drive oncogenesis 16 and in GBM, there is a disproportionately high rate of mutation in chromatin modifiers. 17 The epigenetic landscape, which is distinct between BTICs and differentiated GBM cells, helps maintain BTIC identity and prevents interconversion between these cell types. 18, 19 This epigenetic barrier between BTICs and non-stem GBM cells can be traversed via epigenetic remodeling that resembles reprogramming of induced pluripotent stem cells. 20 However, there are limited studies about specific epigenetic factors in BTIC regulation, with most focusing on members of the polycomb group and mixedlineage leukemia. 21, 22 The inhibitor of growth (ING) family of epigenetic regulators (ING1-5) affect growth, the DNA damage response, cellular senescence and apoptosis. [23] [24] [25] [26] INGs are stoichiometric components of histone acetyltransferase (HAT) or histone deacetylase (HDAC) complexes [27] [28] [29] and target them specifically to the H3K4me3 mark with their plant homeodomain (PHD) form of zinc finger. 30 Although initially identified as type II tumor suppressors and intensively studied in cancer systems, 31 INGs also function in germ cell development and cell differentiation via epigenetic regulation. [32] [33] [34] ING5 has been reported to regulate cell proliferation, 35, 36 apoptosis, 37 metastasis 38 and chemoresistance 37, 39 in different cancer models. Like other ING family members, ING5 can bind and acetylate p53 by associated HAT complexes, 40, 41 which is assumed to account for most of its inhibitiory effects on proliferation seen in different cancers. 37, [42] [43] [44] However, ING5 also possesses p53-independent functions in promoting the proliferation of several cancer cell lines, probably due to interactions with HBO1 28 and CDK2. 35 ING5 is rarely mutated in cancer but the deregulation of its expression has been reported in many cancer types, with decreased expression in lung cancer and acute myeloid leukemia 36, 44 and increased expression in breast cancer and glioblastoma. 42, 43 Overall, the role of ING5 in cancer appears to be highly tissue specific and a discrepancy between its nuclear and cytoplasmic levels noted in previous studies complicates the investigation of its functions. ING5 appears to be more multifunctional than other ING proteins, being incorporated into the HBO1, MOZ and MORF HAT complexes. 28, 45 ING5 serves as a critical epigenetic regulator for epidermal stem cell maintenance with global co-occupancy with H3K4me3 at genes actively expressed in stem cells and silenced during differentiation. 46 High ING5 levels were also seen in pluripotent cells compared to differentiated lineages, [47] [48] [49] suggesting it may function as a common factor for cell plasticity in stem cell systems.
Since ING5-HAT complexes were reported to function in the maintenance of pluripotent cells (HBO1), 50 hematopoietic stem cells (MOZ) 51 and neural stem cells (MORF), 52 we asked whether ING5 affected stem cell properties of BTICs and indeed, found that it does. ING5 is highly expressed in stem cells where it promotes BTIC self-renewal most strikingly in the absence of growth factors. Pathway analyses indicate ING5 promotes stemness by maintaining intracellular calcium levels and activating the follicle stimulating hormone (FSH) pathway, which co-operatively contribute to BTIC self-renewal, providing novel candidates for targeting BTICs in GBMs.
RESULTS
ING5 maintains BTIC self-renewal E14, R1 and D3 mouse embryonic stem cell lines showed an immediate reduction of ING5 mRNA (Supplementary Figure S1a) and protein (Supplementary Figures S1b, c) as pluripotent cells differentiated. The intrinsic stem cell properties of primary BTIC cultures are best preserved in serum-free medium supplemented with growth factors in which they grow as spheres, 15 and upon 1% serum treatment they differentiate into multiple neural lineages identified by cell type-specific markers (Figure 1a ). In the BT 189 cell strain we also observed decreased ING5 mRNA and protein within the first two days of serum addition (Figures 1b-d) . ING5 immunofluorescence was weak nuclear localization was lost in differentiated cells (Figure 1b) . Two additional cell strains, BT 12 and BT 134 also showed rapid decline of ING5 upon differentiation (Figure 1e ). Sphere formation assays of cells seeded at low density showed that pCI-ING5 transfection increased both the proportion of clonogenic cells (sphere formation rate) and the size of spheres (Figure 1f) . Conversely, ING5 downregulation by siRNA reduced formation and size of spheres (Figure 1g ). To achieve homogeneous knockdown, we constructed lentiviral-based shR-ING5 strains (shR1, shR2) with RFP labels. Two independent knockdown strains showed reduced sphere-forming capability (Figure 1h ) and the shR2 strain (hereafter shR-ING5) with an 80% knockdown efficiency was used in subsequent experiments. The ING5-HBO1 HAT complex was also reported to function in the initiation of DNA replication. 28 To determine if increased sphere-forming rates were due to cell proliferation, we analyzed cell cycle profiles of BTICs after ING5 overexpression and knockdown, but did not observe an effect of ING5 on cell cycle distribution, suggesting that higher sphere-forming ability reflected an increase in asynchronous self renewal of cells (Supplementary Figure S1d) . The expression levels of stem cell core transcription factors OCT4 and OLIG2, and neural stem cell markers CD133 and Nestin were upregulated several-fold by ING5 (Figure 1i ). Induction of Nestin and repression of neuronal lineage marker Tubulin β III (Tubb3) was also seen by western blot in ING5 overexpressing sphere cells ( Figure 1j ) and reciprocal regulation was seen in ING5 knockdown cells (Figure 1k ).
ING5 increases the stem cell pool and inhibits differentiation BTICs grow as heterogeneous populations in vitro with a spectrum of variable self-renewal capabilities. To characterize stem cell hierarchy in BTICs we utilized the CD44 and CD133 cell surface markers, which strongly correlate with the stemness properties and tumor initiating abilities of glioma cells. 53, 54 We used a transposon-based PiggyBac system (iPB) for stable and inducible ING5 overexpression. 55 iPB-ING5 cells treated by the inducer cumate showed a higher percentage of CD44 and C133 positive cells compared to the control (iPB-ctr) (Figure 2a, upper panels) . Conversely, shR-ING5 reduced CD44 positive cells (Figure 2a , lower panels), indicating that ING5 increased the stem cell pool in BTICs.
Self-renewal is achieved in tissue stem cells through uneven distribution of fate determinants for stemness via asymmetric cell division. 56 In neural stem cells, CD133 specifically marks the apical membrane initiating subsequent asymmetric division. 57 Since ING5 reciprocally altered CD133 levels, we tested if ING5 also altered symmetry of cell division. In our mitotic pair analysis, the distribution of Nestin was used as an indicator for three division modes, symmetric proliferating, symmetric differentiating and asymmetric division (Figure 2b) . Despite a high proportion of symmetric division probably due to perturbed asymmetric machinery in tumor initiating cells, 58 ING5 induced a more than two-fold increase of asymmetric divisions (highlighted by the white arrowhead in Figure 2b Enhanced mitogenic signaling by ING5 promotes long-term self-renewal We next performed a more stringent sphere formation assay in the absence of growth factors. EGF and FGF are required to support propagation of neural stem cells and BTICs in vitro. 59, 60 Sphere formation was substantially impaired without EGF and FGF, but under these conditions ING5 more strongly promoted sphere formation (Figure 3a) . ING5 maintained long-term selfrenewal over serial sphere passages, strongly contrasting with the complete exhaustion of stem cells seen in the control group (Figures 3a and b and Supplementary Figures S2c, d ). To test if this correlated with mitogenic signaling, we used the kinase inhibitors Tofacitinib, PX-866 and PD184352 that target the JAK/STAT, PI3K/ Akt and MEK pathways, respectively. Tofacitinib impaired sphere formation in both control and ING5 overexpressing groups (Figure 3c ). However, ING5 overexpressing cells displayed resistance to the MEK1/2 and PI3K inhibitors and retained sphere-forming ability compared to controls (Figure 3c ). Consistent with this, ING5 increased levels of phosphorylated AKT and ERK1/2 ( Figure 3d ) and inhibiting either PI3K or MEK1/2 induced the neuronal lineage marker Tubb3 and suppressed Nestin in both iPB-ING5 and iPB-ctr cells (Figure 3e ). We also found that inhibition of the MEK/ERK pathway, but not PI3K/AKT signaling, reduced the CD133 positive pool in the BTIC population from 76 to 52% (Figure 3f) . Therefore, the MEK/ERK pathway appears to be more directly related to ING5-mediated self-renewal of BTICs than the other pathway tested. Figure S3a) . GO analysis also generated a high ranking for the category including the neurotrophic tyrosine receptor kinases NTRK1 and NTRK2, which was corroborated using qPCR (Figures 4e and f) . These NTRKs can activate MAPK in the absence of EGF 61 Figure S4a) . A reduction of the Ca2+-high population was seen consistently in shR-ING5 cells, while in iPB-ING5 cells a shift to the Ca2+-high population was seen (Figures 5c and d) . Ca2+ signaling positively correlates with GBM cell survival 63, 64 and promotes stem cell features in lung cancer cells. 65 To ask if Ca2+ levels correlated with BTIC stem cell properties, we tested the effects of Ca2+ modulators on single cell sphere formation. Ionomycin and cyclopiazonic acid (CPA) increase intracellular Ca2 + through plasma membrane import and store-operated entry, respectively (Supplementary Figure S4b) , and they both promoted sphere-forming capabilities, with the rates of sphere formation in knockdown cells nearing the level seen in the untreated (DMSO) shR-ctr group (Figure 5e ). By contrast, treatment with the Ca2+ chelator BAPTA-AM, or the L-type (Nifedipine) and T-type (SKF96365) Ca2+ channel blockers reduced intracellular Ca2+ levels and decreased sphere-forming capabilities (Figure 5e ). Ionomycin and CPA treatment also increased the pool of CD133 positive BTICs (Figure 5f ). The above reagents did not induce cell apoptosis at the concentrations used, as estimated by cell morphology and PARP cleavage (Supplementary Figure S4c) .
Since Ca2+ signaling is closely associated with PI3K and MAPK signaling pathways through downstream effectors PKC, calcineurin (CaN) and calmodulin-dependent kinases (CAMKs), we tested whether increasing Ca2+ affected these pathways in BTICs. We found both phosphorylated AKT and ERK were elevated by Ionomycin treatment (Figure 5g FSHR can activate the MAPK pathway 67 and induces a stem celllike phenotype through the ERK-OCT4 axis in ovarian cancer cells. 68, 69 The FSH pathway plays essential roles in follicular development and germ cell generation, 70 while its function in brain cells remains unexplored. The Cancer Genome Atlas (TCGA) data showed modest expression levels of FSHR and FSHB in GBM, but we found that ING5 strongly induced the level of FSH receptors on the plasma membrane (Figure 6e ). To test if this pathway affected GBMs, we treated cells with an FSHR neutralizing antibody (anti-FSHR) that blocks ligand-receptor binding. This compromised sphere-forming ability in iPB cells to a degree comparable with the calcium inhibitors (Figure 6a ). Anti-FSHR treatment also decreased the CD133 positive population (Figure 6f ) and promoted neuronal differentiation (Figure 6g ) compared to the IgG isotype control. Adding recombinant FSH increased sphere-forming ability in shRNA cell lines and iPB-ctr cells, but not in the iPB-ING5 group, probably because the activation of the FSH pathway had reached a saturation point (Figures 6h and i) .
Although FSH increases intracellular calcium in ovarian granulosa cells, 71 we did not observe changes in calcium levels by anti-FSHR treatment. Treating cells concomitantly with FSHR neutralizing antibody and BAPTA caused an additive effect in inhibiting self-renewal (Figure 6j ), indicating that the two pathways induced by ING5 primarily function independently to promote selfrenewal. OCT4 and Nestin expression was also increased by recombinant FSH (Figure 6k ), suggesting that induction of OCT4 may be a major effector of the FSH pathway in promoting BTIC stem cell properties.
The PHD motif of ING5 is required for maintaining BTIC stemness Since the PHD of ING proteins interacts specifically with H3K4Me3 to target HAT and HDAC complexes to remodel chromatin, 27, 72 we asked if an intact PHD was needed for iING5 function in BTIC selfrenewal. Sphere formation ability of iPB cells overexpressing ING5 lacking the PHD (ΔPHD) was indistinguishable from the negative control (Figures 7a and b Figure S5c) subtypes. It has been reported that BTIC lines exhibiting typical stem cell properties, but not progenitor features align with a Proneural signature. 73 Single cell RNA-seq revealed that stemness signature was strongest in Proneural and Classical subtypes, 74 suggesting that ING5 may be more relevant to the prognosis of tumors driven by the properties of stem cells.
Gene expression in 169 GBM samples revealed a linear relationship between the expression of SOX2 and RAF1 with ING5 (Supplementary Figure S5d; Supplementary Table S2 ). SOX2 is a master regulator and marker for stemness in neural stem cells. 75 We stratified ING5 and SOX2 by median value, and a clear correlation between ING5 and SOX2 levels was shown in the crosstabulation (Supplementary Figure S5e) with the impact of ING5 on survival strong in the SOX2-Low (Figure 7g ) but not the SOX2-High (Supplementary Figure S5f) group.
DISCUSSION
To examine the role of ING5 in GBM we conducted sphere formation assays, CD44/CD133 profiling, asymmetric division analyses and differentiation assays, all of which indicated that ING5 functions to promote stemness of BTICs. Growth factorreceptor tyrosine kinase (RTK) signaling pathways are essential to preserve BTIC stem cell properties in vitro and we found that ING5 promoted self-renewal for several serial passages in the absence of growth factors, correlating closely with activation of the PI3K and MEK/ERK pathways. Transcriptome analyses also indicated that ING5 promotes mitogenic signaling through RAF1, NTRK receptors and calcium signaling. The PI3K and RAS/ERK pathways have been reported to block differentiation and induce dedifferentiation in mature neural lineages during gliomagenesis. 76 Our results suggest that both the ERK and PI3K pathways inhibit neuronal differentiation in BTICs and the MEK/ERK pathway could also affect the CD133 positive stem cell pool. ERK signaling is known to antagonize neuronal differentiation by promoting OLIG2 expression 77 and ING5 induces the expression of OLIG2, possibly mediated by the MEK/ERK pathway.
The PHD of ING5, which facilitates the targeting of HAT complexes to gene promoters containing the H3K4Me3 mark, 45 is required for ING5's stemness-promoting function and binding to the proximal promoter regions of target genes. Consistent with the generally positive effects of HATs on gene expression, our transcriptome analysis indicates ING5 mainly functions through gene activation, representing a distinct, and possibly complementary mechanism from the well-known stemness factor PRC2 in BTIC maintenance by silencing the BMP4-induced differentiation pathway. 
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In GBM, a number of RTKs and GPCRs activated by extracellular signals can potentially mobilize the second messenger Ca2+, however such a role of Ca2+ in BTIC regulation was previously unknown. We found that ING5 maintained relatively high levels by increased activity of membrane channels, and that such Ca2+ concentrations are required for self-renewal of BTICs. Calcium signaling is also closely associated with mitogenic pathways and we observed enhanced phosphorylation of AKT and ERK by increasing intracellular Ca2+ levels. We further found that CaN was a critical effector of Ca2+ signals that could potentially connect to the MEK pathway through its substrate KSR2.
Glycoproteins and steroid hormones have been reported to regulate different aspects of neurodevelopment and neural stem cell properties, where they usually play neurotrophic roles. [79] [80] [81] We found that the FSH pathway was activated by ING5, with ING5 overexpression increasing levels of membrane bound FSH receptors. Blocking the FSH pathway also reduced the ability of BTICs to self-renew. In ovarian cancer cells FSH activates OCT4 expression through the ERK pathway. 69 Here we found that FSH treatment increased OCT4 expression in BTICs, suggesting a mechanism shared in both cell types. ING5 also activated a network of genes involved in hormone signaling and steroidogenesis (Supplementary Figure S3d) . Among these, NR5A1 (Figure 6c ) has a central function in regulating steroidogenesis and the expression of a variety of hormones. NR5A1 also helps induce a ground state of pluripotency and OCT4 expression 82, 83 suggesting that ING5 has a function in activating the steroidogenesis-hormone network universally in pluripotent and cancer stem cell systems.
ING5 has more often been described as a tumor suppressor although some multi-faceted effects were also observed, such as inhibition of chemoresistance and apoptosis. 37, 43 In contrast, our study shows that ING5 plays an oncogenic role in brain tumors by enhancing the self-renewal of stem-like cancer cells. It is clear from previous studies that the functions of ING5 are highly dependent on its interaction partners. In this study since the major cell line used (BT 189) harbors homozygous p53 mutation R273C which greatly alters its target gene pattern, 73, 84 we predict that the role of ING5 is not dependent on p53, which is consistent with an undisturbed cell cycle profile in ING5-manipulated cells.
Important roles of HAT enzymes and cofactors in the ING5-HAT complexes have been documented in mammalian brain development. Disruption of acetyltransferase MORF causes severe defects in brain development and adult neurogenesis in mice, 52, 85 and is associated with multiple neurodevelopmental disorders in human. [86] [87] [88] Deficiency of BRPF1, a cofactor present in the same complexes as ING5, leads to neocortical and hippocampus abnormalities of mice. 89, 90 These complexes are believed to play a critical role in promoting neural stem cell characteristics, 91, 92 however an understanding of the mechanism(s) by which they promote stem cell character and correlation with brain tumor development is still lacking. Our results highlight the requirement of ING5 for maintaining BTIC stem cell properties, suggesting that proper targeting of associated complexes is critical for maintaining stemness.
In summary, we find that ING5 promotes stem cell properties of BTICs by inducing calcium and FSH signaling pathways, which stimulate PI3K/AKT and MEK/ERK signaling. The stem cell factors OCT4, OLIG2 and Nestin were subsequently activated. Our data suggest FSH and calcium signaling primarily function through distinct mechanisms, involving the CaN axis and the activation of OCT4, respectively. These effects were dependent on the PHD motif of ING5, which targets HAT complexes to activate gene expression as outlined in the model shown in Figure 7h . BTICs are the drivers of tumor initiation and recurrence in GBMs and are difficult to eradicate due to their stem cell properties. We suggest that besides pharmaceutically targeting ING5 itself, the FSH and calcium signaling pathway could also serve as targets and may prove useful in combination with the current PI3K and MEK pathway inhibitors being tested, to diminish stem cell properties, and hence the propensity for BTIC-based GBM to recur.
MATERIALS AND METHODS
BTIC cultures and sphere formation assays BTIC lines BT 12, BT 134 and BT 189 were established from adult GBM patients as described previously. 6 Neurospheres were kept in serum free media and supplemented with 20 ng/ml EGF (Peprotech, Rocky Hill, NJ, USA), 20 ng/ml FGF (R&D Systems, Minneapolis, MN, USA) and 2 μg/ml heparin solution (STEMCELL, Vancouver BC, CA, USA). For sphere formation assays, 200 viable single cells were grown for 12-14 days in each well of 96-well plates. The complete field of each well was captured under a × 4 microscope objective and the diameter of each sphere measured. At least three wells (600 cells) were counted for each condition in one experiment. Serial sphere assays were conducted by harvesting all of the cells from the last passage and replating them into new wells at the same dilution. Assays with treatment by protein kinase inhibitors, calcium modulators and other reagents were conducted in the absence of growth factors. All statistical analyses were done by Student t-test (unpaired, two-sided).
Sphere cell differentiation and immunofluorescence
BTICs were plated on poly-L-ornithine coated glass coverslips and induced to differentiate in serum free media supplemented with 1% fetal bovine serum (Invitrogen, Carlsbad, CA, USA) for 5-7 days. For immunofluorescence assays, cells were fixed with 4% formaldehyde, permeabilized with 0.5% Triton X-100 and then incubated with the primary antibodies against Nestin (1: 800; MAB-1259, R&D Systems), Tubb3 (1:400; MRB-435P, Biolegend, San Diego, CA, USA), GFAP (1:200; Z0334, Dako, Glostrup, Denmark) or FSHR (1:30, MAB65591, R&D Systems) at 4°C overnight as described. 93 After incubation with fluorophore-conjugated secondary antibodies (Invitrogen) and Hoechst 33258 (Sigma, St Louis, MO, USA) at 37°C, coverslips were examined under an Olympus IX71 wide-field microscope. At least three independent experiments were performed and representative fields are shown in the immunofluorescence results.
Asymmetry studies
The division mode analysis was performed on mitotic pairs seeded at low density on coated coverslips. Cells were synchronized using the double thymidine block method and released for 18-20 h before being fixed and immunostaining for Nestin. Quantitative real-time PCR Total RNA was isolated using TRIzol (Invitrogen) reagent and reverse transcription was conducted using the Applied Biosystems (Foster City, CA, USA) cDNA Reverse Transcription kit. Real-time qPCR reactions were carried out using Maxima SYBR Green qPCR Mastermix (Fermentas, Waltham, MA, USA) on the QuantStudio 6 Flex real-time PCR system (Applied Biosystems).
Plasmid transfection and PiggyBac overexpression

Gene expression microarray and data analysis
This information is provided in the Expanded View section. Primary data are available through the GEO access number GSE100398 that can be viewed at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE100398.
Antibodies and chemicals
This information is provided in the Expanded View section.
Flow cytometry
Live cells were incubated with conjugated antibodies CD133-PE (1:100; 12-1338, eBioscience, San Diego, CA, USA) and CD44-FITC (1:50; ab19622, abcam, Cambridge, UK) at 4°C for 30 min. PE Mouse IgG1 kapa (400111, Biolegend) and FITC Rat IgG2b (400633, Biolegend) were used as isotype controls. After washing with PBS, cells were re-suspended in 300 μl PBS and examined on an LSR II flow cytometer (BD Biosciences, San Jose, CA, USA). Data analysis was performed using FlowJo software (Tree Star, Inc., Ashland, OR, USA). For calcium detection, live cells were loaded with 5 μM Fluo3-AM (Sigma) for 45 min at 37°C, washed with PBS, and checked on the flow cytometer. For cell cycle analysis, transfected cells were dissociated into single cell suspension and fixed in 70% ethanol. After washing with PBS, cells were treated with RNase (0.2 mg/ml) and stained in propidium iodide solution (10 μg/ml) and then analyzed by flow cytometry.
Live cell calcium imaging
Cells were cultured on poly-L-ornithine coated dishes overnight in the absence of growth factors, and then incubated in medium containing 5 μM Fluo3-AM at 37°C for 30 min. After washing with PBS, cells were deesterified for 30 min and examined under a fluorescence microscope. For co-transfection experiments (Supplementary Figure S4a) , the calcium level was quantified using ImageJ software.
Chromatin immunoprecipitation
About 5 × 10 6 BTICs were used for each IP condition which were first dissociated and crosslinked with 1% formaldehyde. Cells were lysed in ChIP lysis buffer as described previously. 94 Extracts were sonicated for 10 times (10 s each). An aliquot of 50 μl of lysates were kept as input controls and the rest were incubated overnight with the ING5 antibody, FLAG M2 Affinity Gel (A2220, Sigma), rabbit/mouse IgG controls (Santa Cruz, Dallas, TX, USA), respectively, followed by protein A and protein G Sepharose (GE Healthcare, Little Chalfont, UK) incubation for 2 h (except for the M2-gel treated samples). Agarose Beads were then washed and eluted as described. 94 The eluate was de-crosslinked and DNA isolated using phenol-chloroform and ethanol.
Statistics
All t-tests were performed in GraphPad Prism and results were displayed as the mean ± s.e.m. At least three independent experiments were performed to obtain adequate power for the statistical analyses. Linear regression, Pearson Correlation and Kaplan Meier analyses were performed using SPSS Statistics software (IBM, Armonk, NY, USA). For the overall Kaplan Meier analysis on TCGA data, all available GBM cases (n = 114) were included and for subtype-specific analyses, G-CIMP subtype was excluded due to small sample size (n = 6). The gene expression data from TCGA GBM cohorts were not assumed to be normally distributed and the Pearson and linear regression analyses were performed accordingly.
GEO access. Primary data are available through the GEO access number GSE100398 that can be viewed at https://www.ncbi.nlm.nih.gov/geo/ query/acc.cgi?acc=GSE100398.
